Mlodipine (2017-03-29)

Amlodipine Recall Summary Amlodipine, a blood pressure medication, was recalled across Canada in March 2017 due to product safety concerns. The recall was classified as Class I, meaning there is a reasonable possibility that the product could cause serious adverse health effects or death. This recall affected amlodipine products distributed throughout Canada.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2017-04-10

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/1e107aee-568a-422e-8439-f3e009ed3ecc